Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activationXueyan Cao(Second Affiliated Hospital of Nanjing Medical University), Lin Miao(Second Affiliated Hospital of Nanjing Medical University)BMC CancerMay 23, 202310.1186/s12885-023-10954-8Cited by 21SaveCiteExport RISWatch citationsRelated PapersNK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway|Oncology Reports|2013|12